Many reviews of molecular profiling strategies have highlighted the importance of analyzing molecular data in conjunction with other clinical measures of severity (i.e., APACHE, SOFA scores), markers of infection (i.e., procalcitonin), and markers of inflammation (i.e., IL-6, IL-10) [69–72]. The gene discussed is IL10; the disease is infection.